Depression
Pipeline by Development Stage
On Market (7)
Approved therapies currently available
Competitive Landscape
29 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 49 trials with date data
Clinical Trials (50)
Total enrollment: 173,942 patients across 50 trials
Imaging the Nucleus Accumbens in Major Depressed Patients 'Treated With Pramipexole
Lithium and Standard Therapy in Resistant Depression
A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression
Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression
Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
A Trial of AXS-05 in Patients With Major Depressive Disorder
Understanding How Anaesthesia Affects ECT Outcomes
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Omega-3 Fatty Acids for Treatment of Depression in Adolescents
Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.
Study Evaluating Effexor XR in Elderly Patients With Major Depression.
A Randomised Trial of Sertraline, Cognitive Behaviour Therapy & Combined Therapy for Postnatal Depression
Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain
A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression
Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
Clinical Outcomes With Electroconvulsive Therapy: Insights From Computational Modelling
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
This is a Study to Determine the Antidepressant Effects of AZD6765
AZD6765 Severe Major Depressive Disorder (MDD) IV
AZD6765 for Treatment Resistant Depression
An Expert System to Reduce Depression in Primary Care
To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin Tablets
PK Study of Multi-dose Trazodone Hydrochloride Prolonged-released Tablets in Healthy Chinese
PK Study of Diet Effect of Trazodone Hydrochloride Prolonged-Released Tablets in Healthy Chinese
Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration
A Blinded, Four-Way Crossover in Healthy Subjects to Assess EEG After Administration of Ketamine, Placebo and AZD6765
A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood Levels
Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects
AZD6765 Oral Single Ascending Dose/Multiple Ascending Dose (SAD/MAD)
Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET)
A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease
To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions
To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg
To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions
To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets
To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg Tablets
Sound Bite-- a Therapeutic Song-writing Program
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
Retrospective Analyses of TrakStar Database
Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation
Heart-Smile Training Intensive Introduction Program
Meru Health Program for Cancer Patients With Depression and Anxiety
Clinical Study on the Safety and Efficacy of Dental Pulp Mesenchymal Cells in the Treatment of Depression
Reward Emotion Learning and Ketamine Study
Assessing an EEG Biomarker of Response to TMS for Major Depression